Exhibit 107
Calculation of Filing Fee Tables
Form S-3
(Form Type)
Sonnet BioTherapeutics Holdings, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered and Carry Forward Securities
| Security Type | Security Class Title | Fee Calculation or Carry Forward Rule | Amount Registered(2) | Proposed Maximum Offering Price Per Share(2) | Maximum Aggregate Offering Price | Fee Rate | Amount of Registration Fee | |||||||||||||||||||
| Equity (1) | Common Stock, $0.0001 par value per share | — | — | — | — | — | — | |||||||||||||||||||
| Equity (1) | Preferred Stock, $0.0001 par value per share | — | — | — | — | — | — | |||||||||||||||||||
| Debt (1) | Debt Securities | — | — | — | — | — | — | |||||||||||||||||||
| Other (1) | Warrants | — | — | — | — | — | — | |||||||||||||||||||
| Other (1) | Units | — | — | — | — | — | — | |||||||||||||||||||
| Other | Subscription Rights | — | — | — | — | — | — | |||||||||||||||||||
| Unallocated (Universal) Shelf (1) | — | 457 | (o) | — | (3 | ) | $ | 100,000,000 | 0.00014760 | $ | 14,760.00 | |||||||||||||||
| Total Offering Amounts | $ | 14,760.00 | ||||||||||||||||||||||||
| Total Fees Previously Paid | — | |||||||||||||||||||||||||
| Total Fee Offsets | $ | — | ||||||||||||||||||||||||
| Net Fee Due | $ | 14,760.00 | ||||||||||||||||||||||||
| (1) | Represents securities that may be offered and sold from time to time in one or more offerings by Sonnet BioTherapeutics Holdings, Inc. |
| (2) | There are being registered hereunder an indeterminate number of shares of common stock and preferred stock, an indeterminate principal amount of debt securities, an indeterminate number of warrants to purchase common stock, preferred stock or debt securities, an indeterminate number of units, and an indeterminate number of subscription rights to purchase an indeterminate number of common stock or preferred stock, from time to time, which together shall have an aggregate initial offering price not to exceed $100,000,000. If any debt securities are issued at an original issue discount, then the offering price of such debt securities shall be in such greater principal as shall result in an aggregate offering price not to exceed $100,000,000 less the aggregate dollar amount of all securities previously issued hereunder. Any securities registered hereunder may be sold separately or as units with other securities registered hereunder. The proposed maximum offering price of the securities will be determined, from time to time, by the Registrant in connection with the issuance by the Registrant of the securities registered hereunder. The securities registered hereunder also include an indeterminate number of shares of common stock and preferred stock and amount of debt securities as may be issued upon conversion of or exchange for preferred stock or debt securities that provide for conversion or exchange, upon exercise of warrants or subscription rights or pursuant to the anti-dilution provisions of any the securities registered hereunder. In addition, pursuant to Rule 416 under the Securities Act of 1933, as amended, or the Securities Act, the shares being registered hereunder include an indeterminate number of shares of common stock and preferred stock as may be issuable with respect to the shares being registered hereunder as a result of stock splits, stock dividends or similar transactions. |
| (3) | The proposed maximum aggregate offering price per class of security will be determined from time to time by the Registrant in connection with the issuance by the Registrant of the securities registered hereunder and is not specified as to each class of security pursuant to General Instruction II.D. of Form S-3 under the Securities Act. |